Evidence map›Paper›PMID 29949887›Full record

ReviewInternational journal of molecular sciences2018

FGF Family: From Drug Development to Clinical Application.

Qi Hui, Zi Jin, Xiaokun Li, Changxiao Liu, Xiaojie Wang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. [Advances on efficacy and mechanisms of acid fibroblast growth factor for promoting injured tissue repair].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026
    Review
  11. Article
  12. Proteome-Guided Drug Target Discovery for Periodontitis.Journal of clinical periodontology · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review of the 100 Most Cited Articles inEuropean burn journal · 2025
    Review
  18. Article
  19. Review
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Qi HuiSchool of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China. huiqi1976@163.com.
Zi JinSchool of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China. 18858818119@163.com.
Xiaokun LiSchool of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China. lixk1964@163.com.
Changxiao LiuSchool of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China. liuchangxiao@163.com.
Xiaojie WangSchool of Pharmacy, Wenzhou Medical University, Chashan University Park, Wenzhou 325035, China. wangxiaojie1972@126.com.
Wenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factor (FGF) belongs to a large family of growth factors. FGFs use paracrine or endocrine signaling to mediate a myriad of biological and pathophysiological process, including angiogenesis, wound healing, embryonic development, and metabolism regulation. FGF drugs for the treatment of burn and ulcer wounds are now available. The recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in maintaining homeostasis of bile acid, glucose, and phosphate further extended the activity profile of this family. Here, the applications of recombinant FGFs for the treatment of wounds, diabetes, hypophosphatemia, the development of FGF receptor inhibitors as anti-neoplastic drugs, and the achievements of basic research and applications of FGFs in China are reviewed.

Indexed as

Clinical Trials as TopicDrug DiscoveryAnimalsFibroblast Growth FactorsHumansPhylogenyReceptors, Fibroblast Growth FactorFibroblast Growth FactorsReceptors, Fibroblast Growth Factorclinical applicationdrug developmentfibroblast growth factorfibroblast growth factor receptor inhibitormetabolic regulationwound healing

Identifiers

PMID29949887
PMCPMC6073187
OpenAlexW2810659030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.